NFKB1 and atherosclerosis: The liberated NF-κB then translocates into the nucleus where it activates the expression of downstream target genes, including those which encode proinflammatory cytokines, cell adhesion molecules and chemotactic factors, and contributes to the acceleration of atherosclerosis [9]–[13].